article thumbnail

DrugPatentWatch named “Best of the Web” by Genetic Engineering News

Drug Patent Watch

DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile highlighted the “new training modules designed to help you find….

article thumbnail

Plant genetic engineering to fight ‘hidden hunger’

Scienmag

Agriculture Agricultural Production/Economics Biology Biotechnology Food/Food Science Genetics Molecular Biology Nutrition/Nutrients Plant Sciences

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use

The Pharma Data

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use. 14, 2020 — The first genetically engineered pigs for use as food or for potential future biomedical use — such as transplantation — in humans have been approved by the U.S.

article thumbnail

Self-Destructing Malaria-Spreading Mosquitos? How Genetic Engineering Could Make It So

BioSpace

breakthrough study has found that altering the genetic makeup of malaria-carrying mosquito species could be the key to stopping the spread of the malaria virus and finally eradicating the disease

article thumbnail

#news #biotech Restoring eyesight with genetically engineered stem cells

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Restoring eyesight with genetically engineered stem cells.Restoring eyesight with genetically engineered stem cells arlene.weintraub Mon, 11/30/2020 – 09:46 from FierceBiotech: Biotech [link].

article thumbnail

#news #biotech Plant genetic engineering to fight hidden hunger

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Plant genetic engineering to fight hidden hunger.More than 2 billion people worldwide suffer from micronutrient malnutrition due to deficiencies in minerals and vitamins.

article thumbnail

#news #biotech The plan to release genetically engineered mosquitoes in California

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: The plan to release genetically engineered mosquitoes in California.In the mosquito breeding rooms of British biotech company Oxitec, scientists line up fresh eggs, each the size of … Continue reading → #news

article thumbnail

#news #biotech Taking the guesswork out of genetic engineering: STAMPScreen pipeline helps streamline genetic studies in mammalian cell

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Taking the guesswork out of genetic engineering: STAMPScreen pipeline helps streamline genetic studies in mammalian cell.Today’s genetic engineers have a plethora of resources at their disposal: an … Continue reading → #news

article thumbnail

Genetic engineering without unwanted side effects helps fight parasites

Scienmag

Around a third of the world’s population carries Toxoplasma gondii, a parasite that puts people with a weakened immune system at risk and can trigger malformations in the womb. The single-celled pathogen also leads to economic losses in agriculture, with toxoplasmosis increasing the risk of abortion among sheep, for example. The parasite has a complex […].

article thumbnail

#news #biotech Genetic engineering without unwanted side effects helps fight parasites

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genetic engineering without unwanted side effects helps fight parasites.Modified CRISPR-Cas9 gene editing scissors are enabling researchers at the University of Zurich to make alterations to the genetic … Continue reading → #news

article thumbnail

Genetically engineered T cells could lead to therapies for autoimmune diseases

Scienmag

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments. Medicine & Health Biotechnology cancer Cell Biology Gene Therapy Genetics Immunology/Allergies/Asthma Medicine/Health

article thumbnail

Genetically modified herpes combats advanced cancers

Pharma Times

A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial

article thumbnail

Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics) – ResearchAndMarkets.com

BioTech 365

Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics) – ResearchAndMarkets.com Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application … Continue reading → Business Wire

article thumbnail

#news #biotech International research team argues for combination of organic farming and genetic engineering

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: International research team argues for combination of organic farming and genetic engineering.For more sustainability on a global level, EU legislation should be changed to allow the use … Continue reading → #news

article thumbnail

Pioneering Gene Therapy Freed Her of Sickle Cell. Is a Cure at Hand?

NY Times

Sickle Cell Anemia Drugs (Pharmaceuticals) Research Clinical Trials Genetic Engineering Genetics and Heredity Race and EthnicitySuch treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results?

article thumbnail

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

article thumbnail

Bone Therapeutics inks iPSC related research partnership

BioPharma Reporter

A new deal sees Bone Therapeutics gain access to iPSC derived, genetically engineered MSCs. Markets & Regulations

article thumbnail

Cáncer sin quimioterapia: una revolución silenciosa

NY Times

Chemotherapy Breast Cancer Lung Cancer Drugs (Pharmaceuticals) Women and Girls Tumors Immunotherapy Genetic Engineering Herceptin (Drug Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.

article thumbnail

Empyrean Grabs $22M to Target CNS Disorders with Plant-Based Platform

BioSpace

Genetic engineering company Empyrean Neurosciences stepped into the CNS arena with $22 million and a small molecule platform derived from plants and fungi

article thumbnail

Is China Using CRISPR to Create Super Soldiers?

BioSpace

Has China discovered a super-soldier formula through the capabilities of genetic engineering? A U.S. government official claims this is exactly what is happening

article thumbnail

Researchers Halt Trial of Promising Sickle Cell Treatment

NY Times

Sickle Cell Anemia Leukemia Bone Marrow Genetic Engineering Clinical Trials Bluebird Bio Inc Williams, David II DNA (Deoxyribonucleic Acid) National Heart, Lung and Blood Institute Busulfan Drugs (Pharmaceuticals

article thumbnail

Engrafting Bacteria for Therapeutic Advantage in Kidney-Related Diseases

BioSpace

Proof of concept for the Genetically Engineered Microbial Medicines (GEMM) platform came in a recent first-in-human, Phase I trial

article thumbnail

Immune therapy targets cells that cause leukemia relapse

Scienmag

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the disease, according to a preclinical study by investigators at Weill Cornell Medicine.

article thumbnail

New technology designed to genetically control disease-spreading mosquitoes

Scienmag

Leveraging advancements in CRISPR-based genetic engineering, researchers at the University of California San Diego have created a new system that restrains populations of mosquitoes that infect millions each year with debilitating diseases.

article thumbnail

China NMPA grants approval for CanSinoBIO’s Covid-19 vaccine as booster

Pharmaceutical Technology

Administered as a single dose, the genetically engineered vaccine has the replication-defective adenovirus type 5 vector that expresses the spike S protein of the SARS-CoV-2 virus.

article thumbnail

RoosterBio and MBL Beijing Biotech team up to accelerate advanced therapy manufacturing in China

BioPharma Reporter

RoosterBio has entered into an exclusive distributor partnership with MBL Beijing Biotech: with RoosterBioâs expansion media, exosome collection media, bioreactor media and genetic engineering media to be sold and distributed by MBL Beijing and thus becoming readily accessible for the first time to MSC and exosome therapy developers in China.

article thumbnail

Lab-grown “mini-kidneys” unlock secrets of a rare disease

Scienmag

As described in Cell Reports, they did this by creating genetically engineered kidney organoids, or “mini-kidneys” grown from human tissue. Technology and Engineering Disease Labgrown minikidneys rare secrets unlock

article thumbnail

Study adds evidence that altered fat metabolism, enzyme, plays key role in Lou Gehrig’s disease

Scienmag

A new study using genetically engineered mice and human cell and tissue samples has added to evidence that higher levels of inflammatory chemicals involved in fat metabolism occur in people with amyotrophic lateral sclerosis (ALS), […]. EMBARGOED TILL MONDAY, NOV. 15, AT 11 A.M.

article thumbnail

QN-023a by Hangzhou Qihan Biotechnology for Relapsed Acute Myeloid Leukemia: Likelihood of Approval

Pharmaceutical Technology

The therapeutic candidate comprises allogeneic NK cells genetically engineered to express chimeric antigen receptors (CAR-NK) targeting cells CD33. QN-023a is under clinical development by Hangzhou Qihan Biotechnology and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to GlobalData, Phase I drugs for Relapsed Acute Myeloid Leukemia have a 71% phase transition success rate (PTSR) indication benchmark for progressing into Phase II.

article thumbnail

Molecule holds promise to reprogram white blood cells for better cancer treatment

Scienmag

In this type of therapy, T cells, a type of white blood cell, are collected from a patient’s blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) […].

article thumbnail

PF-07263689 by Pfizer for Renal Cell Carcinoma: Likelihood of Approval

Pharmaceutical Technology

WO-12 is an oncolytic virus immunotherapy which involves genetically engineered vaccinia virus. PF-07263689 is under clinical development by Pfizer and currently in Phase I for Renal Cell Carcinoma. According to GlobalData, Phase I drugs for Renal Cell Carcinoma have a 75% phase transition success rate (PTSR) indication benchmark for progressing into Phase II.

article thumbnail

Sloan Kettering Institute Scientists retool CAR T cells to serve as ‘micropharmacies’ for cancer drugs

Scienmag

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain types of blood cancers. Now, scientists at Memorial Sloan Kettering Cancer Center’s Sloan Kettering Institute (SKI) have developed new CAR T cells that can do something their […].

article thumbnail

ERS Genomics and Japan SLC Sign CRISPR/Cas9 License Agreement

BioTech 365

article thumbnail

Gene therapy using ‘zinc fingers’ may help treat Alzheimer’s disease, animal study shows

Scienmag

Treatment involving a single injection has long-lasting effects BOSTON – Researchers have used a genetic engineering strategy to dramatically reduce levels of tau–a key protein that accumulates and becomes tangled in the brain during the development of Alzheimer’s disease–in an animal model of the condition.

article thumbnail

ERS Genomics and Setsuro Tech Sign CRISPR/Cas9 License Agreement

BioTech 365

article thumbnail

Researchers engineer cells to destroy malignant tumor cells but leave the rest alone

Scienmag

Credit: McMaster University HAMILTON, ON June 28, 2021 — Researchers at McMaster University have developed a promising new cancer immunotherapy that uses cancer-killing cells genetically engineered outside the body to find and destroy malignant tumors.

article thumbnail

Cataloging nature’s hidden arsenal: Viruses that infect bacteria

Scienmag

And despite the numerous clever drugs and genetic engineering […]. Biology Bacteriology Genetics Microbiology Virology

article thumbnail

CIBMTR Completes Enrollment in Yescarta® Long-Term Post-Marketing Safety Study, 2 Years Ahead of Schedule

BioTech 365

article thumbnail

New approach can add diversity to crop species without breeding GMOs

Scienmag

Agriculture Agricultural Production/Economics Biology Biotechnology Food/Food Science Genes Genetics Plant Sciences

article thumbnail

Leading innovators in IgG gene expressing animal models for the pharmaceutical industry

Pharmaceutical Technology

To obtain human antibody responses within a mouse, mice are genetically engineered to be humanised for their Ig genes.

article thumbnail

New ‘split-drive’ system puts scientists in the (gene) driver seat

Scienmag

Researchers develop tunable system that harnesses the spread of cargo carried by gene drives Credit: Gerard Terradas, UC San Diego Powerful new genetic engineering methods have given scientists the potential to revolutionize several sectors of global urgency.

article thumbnail

New mouse model provides first platform to study late-onset Alzheimer’s disease

Scienmag

April 27, 2021 — University of California, Irvine biologists have developed a new genetically engineered mouse model that, unlike its predecessors, is based on the most common form of Alzheimer’s disease. Biology Alzheimer Genetics Medicine/Health NeurobiologyFirst-of-its-kind advance holds promise for making new strides in research, treatments Irvine, Calif.,

article thumbnail

#news #biotech New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged.Over the past decade, the CRISPR-Cas9 gene editing system has revolutionized genetic engineering, allowing … Continue reading → #news